Multi-step process of human breast carcinogenesis: A role for BRCA1, BECN1, CCND1, PTEN and UVRAG

Molecular Medicine Reports

Volumn 5, Issue 2, 2012, Pages 305-312

  Wu, Tao ^a   Li, Yi ^a   Gong, Li ^a   Lu, Jian Guo ^a   Du, Xi Lin ^a   Zhang, Wen Dong ^a   He, Xian Li ^a   Wang, Jun Qing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Autophagy; Cell cycle; Ductal breast cancer; mRNA in situ hybridization

Indexed keywords

BECLIN 1; BRCA1 PROTEIN; CYCLIN D1; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN; ULTRAVIOLET RADIATION RESISTANCE ASSOCIATED GENE PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CARCINOMA; CELL CYCLE G1 PHASE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; MUCINOUS CARCINOMA; TISSUE MICROARRAY; TUMOR VOLUME;

ADULT; AGED; APOPTOSIS REGULATORY PROTEINS; BRCA1 PROTEIN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CYCLIN D1; FEMALE; G1 PHASE; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; PTEN PHOSPHOHYDROLASE; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 84862918967     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.634     Document Type: Article

References (32)

1. World Health Organization International Agency for Research on Cancer (June 2003): 'World Cancer Report'. http://www.iarc.fr/en/Publications/PDFs- online/World-Cancer-Report/World-Cancer-Report. Retrieved on March 26, 2009.
2. World Health Organization (February 2006): 'Fact sheet No. 297: Cancer'. http://www.who.int/mediacentre/factsheets/fs297/en/index.html. Retrieved on March 26, 2009.
3. Lam WW, Fielding R and Ho EY: Predicting psychological morbidity in Chinese women following surgery for breast cancer. Cancer 103: 637-646, 2005.
4. Cavalieri E, Chakravarti D, Guttenplan J, et al: Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta 1766: 63-78, 2006. (Pubitemid 44175632)
5. Farlex (2005): 'Immunological surveillance, The Free Dictionary: Immunological Surveilliance'. http://medical-dictionary.thefreedictionary.com/ immunological+surveillance immunological surveillance. Retrieved on February 10, 2008.
6. Braddock, Suzanne W, Kercher J and Clark M: Straight Talk About Breast Cancer From Diagnosis to Recovery: A Guide for the Whole Family. Addicus Books, Omaha, 1994.
7. Steeg P and Zhou Q: Cyclins and breast cancer. Breast Cancer Res Treat 52: 17-28, 1998. (Pubitemid 29056082)
8. Loden M, Stighall M, Nielsen NH, et al: The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorigenesis based on pattern of genetic aberrations and inactivation of the pRb node. Oncogene 21: 4680-4690, 2002. (Pubitemid 34833145)
9. Miki Y, Swensen J, Shattuck-Eidens D, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71, 1994. (Pubitemid 24345325)
10. Bienstock RJ, Darden T, Wiseman R, et al: Molecular modeling of the amino-terminal zinc ring domain of BRCA1. Cancer Res 56: 2539-2545, 1996. (Pubitemid 26170691)
11. Scully R, Chen J, Ochs RL, et al: Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90: 425-435, 1997. (Pubitemid 27347233)
12. Simpson L and Parsons R: PTEN: life as a tumor suppressor. Exp Cell Res 264: 29-41, 2001. (Pubitemid 32989079)
13. Mills GB, Lu Y, Fang X, et al: The role of genetic abnormalities of PTEN and the phosphatidylinositol 3-kinase pathway in breast and ovarian tumorigenesis, prognosis and therapy. Semin Oncol 28: 125-141, 2001. (Pubitemid 33065118)
14. Nelen MR, Staveren WC, Peeters EA, et al: Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet 6: 1383-1387, 1997. (Pubitemid 27351082)
15. Aita VM, Liang XH, Murty VV, et al: Cloning and genomic organization of Beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 59: 59-65, 1999. (Pubitemid 29339873)
16. Duan ZL, Peng ZL and Wang ZH: [Expression and involved signal transduction pathway of autophagy gene Beclin-1 in epithelial ovarian cancer]. Sichuan Da Xue Xue Bao Yi Xue Ban 38: 239-242, 2007 (In Chinese).
17. Liang C, Feng P, Ku B, et al: Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat Cell Biol 8: 688-699, 2006.
18. Francesco C and Beth L: The role of autophagy in mammalian development cell makeover rather than cell death. Dev Cell 15: 344-357, 2008.
19. Kononen J, Bubendorf L, Kallioniemi A, et al: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844-847, 1998. (Pubitemid 28331029)
20. Battifora H: The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing. Lab Invest 55: 244-248, 1986.
21. Walsh T, Casadei S, Coats KH, et al: Spectrum of mutations in BRCA1, BRCA2, CHEK2,and TP53 in families at high risk of breast cancer. JAMA 295: 1379-1388, 2006.
22. Lee JW, Jeong EG, Lee SH, Yoo NJ, Lee SH: Somatic mutations of BECN1, an autophagy-related gene, in human cancer. JAMA 115: 750-756, 2007. (Pubitemid 46854994)
23. Liu GY, Luo Q, Xiong B, et al: Tissue array for Tp53, C-myc, CCND1 gene over-expression in different tumors. World J Gastro 47: 7199-7207, 2008.
24. Di Vizio D, Cito L, Boccia A, et al: Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. Oncogene 24: 1882-1894, 2005. (Pubitemid 40462790)
25. Knaevelsrud H, Ahlquist T, Merok MA, et al: UVRAG mutations associated with microsatellite unstable colon cancer do not affect autophagy. Autophagy 7:863-870, 2010.
26. Bautista S and Theillet C: CCND1 and FGFR1 coamplification results in the colocalization of 11q13 and 8p12 sequences in breast tumor nuclei. Genes Chromosomes Cancer 22: 268-277, 1998. (Pubitemid 28304517)
27. Deng CX: BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res 34: 1416-1426, 2006.
28. Zhu XY, Kwon CH, Peter W, et al: PTEN induces G1 cell cycle arrest and decreases cyclin D3 levels in endometrial carcinoma cells. Cancer Res 61: 4569-4575, 2001. (Pubitemid 32685791)
29. Itakura E, Kishi C, Inoue K and Mizushima N: Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Mol Biol Cell 19: 5360-5372, 2008.
30. Cheng L and Lee JS: Beclin1-binding UVRAG targets the class C Vps complex to coordinate autophagosome maturation and endocytic trafficking. Nat Cell Biol 10: 776-787, 2008.
31. Vivanco I and Sawyers CL: The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501, 2002. (Pubitemid 37328931)
32. Burnworth B, Popp S, Stark H-J, et al: Gain of 11q|[sol]|cyclin D1 overexpression is an essential early step in skin cancer development and causes abnormal tissue organization and differentiation. Oncogene 25: 4399-4412, 2006. (Pubitemid 44141628)